skinny.

Latest / Stock Movers

Novartis Slumps, Sandoz Gains, Computacenter Up

Today's biggest winners and losers in the stock market.

On this episode of Stock Movers:

- Novartis suffered its third clinical-trial setback in a week after a treatment for a rare muscle-wasting disease failed a late-stage study. Novartis shares plunged as much as 10% in early Zurich trading, reducing their gain for the year to about 4%, trailing rival Roche.

- Sandoz nudged up its mid-term guidance and set a goal of increasing the number of biosimilars in its portfolio to more than 100 by 2040, from 13 currently.

- Computacenter shares climb as much as 7.4%, reaching a record high, after…

Log in to save or queue this episode.

The skinny

The skinny isn't ready yet — notes appear once the transcript is processed.